Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 609

1.

High-Performance Indirect-Drive Cryogenic Implosions at High Adiabat on the National Ignition Facility.

Baker KL, Thomas CA, Casey DT, Khan S, Spears BK, Nora R, Woods T, Milovich JL, Berger RL, Strozzi D, Clark D, Hohenberger M, Hurricane OA, Callahan DA, Landen OL, Bachmann B, Benedetti R, Bionta R, Celliers PM, Fittinghoff D, Goyon C, Grim G, Hatarik R, Izumi N, Gatu Johnson M, Kyrala G, Ma T, Millot M, Nagel SR, Pak A, Patel PK, Turnbull D, Volegov PL, Yeamans C.

Phys Rev Lett. 2018 Sep 28;121(13):135001. doi: 10.1103/PhysRevLett.121.135001.

PMID:
30312055
2.

Thoracoscopic resection of mediastinal tumor in a patient with azygos continuation of the inferior vena cava.

Komatsu H, Izumi N, Tsukioka T, Inoue H, Hara K, Miyamoto H, Nishiyama N.

Gen Thorac Cardiovasc Surg. 2018 Sep 18. doi: 10.1007/s11748-018-1009-8. [Epub ahead of print]

PMID:
30229437
3.

[Various clinical conditions after successful eradication of hepatitis C virus].

Kurosaki M, Izumi N.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(9):768-776. doi: 10.11405/nisshoshi.115.768. Japanese. No abstract available.

PMID:
30197389
4.

Thermal Temperature Measurements of Inertial Fusion Implosions.

Jarrott LC, Bachmann B, Ma T, Benedetti LR, Field FE, Hartouni EP, Hatarik R, Izumi N, Khan SF, Landen OL, Nagel SR, Nora R, Pak A, Peterson JL, Schneider MB, Springer PT, Patel PK.

Phys Rev Lett. 2018 Aug 24;121(8):085001. doi: 10.1103/PhysRevLett.121.085001.

PMID:
30192614
5.

Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Akahane T, Kurosaki M, Itakura J, Tsuji K, Joko K, Kimura H, Nasu A, Ogawa C, Kojima Y, Hasebe C, Wada S, Uchida Y, Sohda T, Suzuki H, Yoshida H, Kusakabe A, Tamada T, Kobashi H, Mitsuda A, Kondo M, Shigeno M, Ide Y, Morita A, Kitamura T, Abe T, Izumi N.

Hepatol Res. 2018 Sep 1. doi: 10.1111/hepr.13246. [Epub ahead of print]

PMID:
30171740
6.

Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ration in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.

Tsukioka T, Izumi N, Mizuguchi S, Kyukwang C, Komatsu H, Toda M, Hara K, Miyamoto H, Nishiyama N.

Gen Thorac Cardiovasc Surg. 2018 Aug 13. doi: 10.1007/s11748-018-0985-z. [Epub ahead of print]

PMID:
30105630
7.

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.

Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, Ochiai T, Fukuhara T, Kano T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.

J Gastroenterol. 2018 Aug 13. doi: 10.1007/s00535-018-1499-2. [Epub ahead of print]

PMID:
30105510
8.

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection.

Cathcart AL, Chan HL, Bhardwaj N, Liu Y, Marcellin P, Pan CQ, Shalimar, Buti M, Cox S, Parhy B, Zhou E, Martin R, Chang S, Lin L, Flaherty JF, Kitrinos KM, Gaggar A, Izumi N, Lim YS.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct.

PMID:
30038044
9.

Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus.

Yasui Y, Kurosaki M, Komiyama Y, Takada H, Tamaki N, Watakabe K, Okada M, Wang W, Shimizu T, Kubota Y, Higuchi M, Takaura K, Tsuchiya K, Nakanishi H, Takahashi Y, Itakura J, Enomoto N, Izumi N.

Hepatol Res. 2018 Jul 20. doi: 10.1111/hepr.13233. [Epub ahead of print]

PMID:
30030872
10.

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M.

Hepatol Int. 2018 Jul;12(4):356-367. doi: 10.1007/s12072-018-9878-6. Epub 2018 Jul 20.

11.

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.

Suda G, Kurosaki M, Itakura J, Izumi N, Uchida Y, Mochida S, Hasebe C, Abe M, Haga H, Ueno Y, Masakane I, Abe K, Takahashi A, Ohira H, Furuya K, Baba M, Yamamoto Y, Kobayashi T, Kawakami A, Kumagai K, Terasita K, Ohara M, Kawagishi N, Umemura M, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.

J Gastroenterol. 2018 Jul 17. doi: 10.1007/s00535-018-1495-6. [Epub ahead of print]

PMID:
30019127
12.

Risk factors and health consequences of physical and emotional violence against children in Zimbabwe: a nationally representative survey.

Chigiji H, Fry D, Mwadiwa TE, Elizalde A, Izumi N, Baago-Rasmussen L, Maternowska MC.

BMJ Glob Health. 2018 Jun 26;3(3):e000533. doi: 10.1136/bmjgh-2017-000533. eCollection 2018.

13.

Fusion Energy Output Greater than the Kinetic Energy of an Imploding Shell at the National Ignition Facility.

Le Pape S, Berzak Hopkins LF, Divol L, Pak A, Dewald EL, Bhandarkar S, Bennedetti LR, Bunn T, Biener J, Crippen J, Casey D, Edgell D, Fittinghoff DN, Gatu-Johnson M, Goyon C, Haan S, Hatarik R, Havre M, Ho DD, Izumi N, Jaquez J, Khan SF, Kyrala GA, Ma T, Mackinnon AJ, MacPhee AG, MacGowan BJ, Meezan NB, Milovich J, Millot M, Michel P, Nagel SR, Nikroo A, Patel P, Ralph J, Ross JS, Rice NG, Strozzi D, Stadermann M, Volegov P, Yeamans C, Weber C, Wild C, Callahan D, Hurricane OA.

Phys Rev Lett. 2018 Jun 15;120(24):245003. doi: 10.1103/PhysRevLett.120.245003.

PMID:
29956968
14.

Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer.

Mizuguchi S, Izumi N, Tsukioka T, Komatsu H, Nishiyama N.

J Cardiothorac Surg. 2018 Jun 27;13(1):78. doi: 10.1186/s13019-018-0763-0.

15.

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, Higuchi M, Kubota Y, Wang W, Okada M, Enomoto N, Izumi N.

PLoS One. 2018 Jun 18;13(6):e0198812. doi: 10.1371/journal.pone.0198812. eCollection 2018.

16.

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K.

Sci Rep. 2018 May 21;8(1):7958. doi: 10.1038/s41598-018-26217-7.

17.

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T.

Gastroenterology. 2018 Sep;155(3):705-718. doi: 10.1053/j.gastro.2018.05.025. Epub 2018 May 17.

18.

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.

Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110; GS-US-320-0108 Investigators.

J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17.

PMID:
29756595
19.

Pulmonary Resection for Lung Cancer Following Transcatheter Aortic Valve Implantation for Severe Aortic Valve Stenosis: A Case Report.

Komatsu H, Izumi N, Tsukioka T, Chung K, Toda M, Hara K, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2018 Apr 26. doi: 10.5761/atcs.cr.18-00028. [Epub ahead of print]

20.

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method.

Tamaki N, Koizumi Y, Hirooka M, Yada N, Takada H, Nakashima O, Kudo M, Hiasa Y, Izumi N.

Hepatol Res. 2018 Sep;48(10):821-828. doi: 10.1111/hepr.13179. Epub 2018 May 18.

PMID:
29679473
21.

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.

Mashiba T, Joko K, Kurosaki M, Ochi H, Osaki Y, Kojima Y, Nakata R, Goto T, Takehiro A, Kimura H, Mitsuda A, Kawanami C, Uchida Y, Ogawa C, Kusakabe A, Narita R, Ide Y, Abe T, Tsuji K, Kitamura T, Okada K, Sohda T, Shigeno M, Satou T, Izumi N.

PLoS One. 2018 Apr 16;13(4):e0194704. doi: 10.1371/journal.pone.0194704. eCollection 2018.

22.

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.

Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura KI, Johnson P, Arai Y; SILIUS study group.

Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7.

PMID:
29631810
23.

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Tsuji K, Kurosaki M, Itakura J, Mori N, Takaki S, Hasebe C, Akahane T, Joko K, Yagisawa H, Takezawa J, Nakata R, Kusakabe A, Kojima Y, Kimura H, Tamada T, Kobashi H, Mitsuda A, Kondou M, Ogawa C, Uchida Y, Sohda T, Narita R, Izumi N.

J Gastroenterol. 2018 Oct;53(10):1142-1150. doi: 10.1007/s00535-018-1455-1. Epub 2018 Apr 6.

PMID:
29626296
24.

Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.

Kaibori M, Yoshii K, Hasegawa K, Ogawa A, Kubo S, Tateishi R, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2018 Mar 30. doi: 10.1097/SLA.0000000000002751. [Epub ahead of print]

PMID:
29608544
25.

Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.

Fujii H, Kimura H, Kurosaki M, Hasebe C, Akahane T, Yagisawa H, Kato K, Yoshida H, Itakura J, Sakita S, Satou T, Okada K, Kusakabe A, Kojima Y, Kondo M, Morita A, Nasu A, Tamada T, Okushin H, Kobashi H, Tsuji K, Joko K, Ogawa C, Uchida Y, Mitsuda A, Sohda T, Ide Y, Izumi N.

Hepatol Res. 2018 Aug;48(9):746-756. doi: 10.1111/hepr.13070. Epub 2018 May 17.

PMID:
29480939
26.

Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.

Tsukioka T, Izumi N, Kyukwang C, Komatsu H, Toda M, Hara K, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2018 Jun 20;24(3):121-126. doi: 10.5761/atcs.oa.17-00215. Epub 2018 Feb 16.

27.

PNLDC1, mouse pre-piRNA Trimmer, is required for meiotic and post-meiotic male germ cell development.

Nishimura T, Nagamori I, Nakatani T, Izumi N, Tomari Y, Kuramochi-Miyagawa S, Nakano T.

EMBO Rep. 2018 Mar;19(3). pii: e44957. doi: 10.15252/embr.201744957. Epub 2018 Feb 14.

28.

Transcriptome profiling reveals infection strategy of an insect maculavirus.

Katsuma S, Kawamoto M, Shoji K, Aizawa T, Kiuchi T, Izumi N, Ogawa M, Mashiko T, Kawasaki H, Sugano S, Tomari Y, Suzuki Y, Iwanaga M.

DNA Res. 2018 Jan 17. doi: 10.1093/dnares/dsx056. [Epub ahead of print]

29.

Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization.

Yasui Y, Tsuchiya K, Kurosaki M, Takeguchi T, Takeguchi Y, Okada M, Wang W, Kubota Y, Goto T, Komiyama Y, Higuchi M, Takaura K, Hayashi T, Takada H, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Enomoto N, Himeno Y, Izumi N.

Hepatol Res. 2018 May;48(6):442-450. doi: 10.1111/hepr.13048. Epub 2018 Feb 9.

PMID:
29278654
30.

Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.

Takayasu K, Arii S, Sakamoto M, Matsuyama Y, Kudo M, Kaneko S, Nakashima O, Kadoya M, Izumi N, Takayama T, Ku Y, Kumada T, Kubo S, Kokudo T, Hagiwara Y, Kokudo N; Liver Cancer Study Group of Japan.

Liver Int. 2018 Mar;38(3):484-493. doi: 10.1111/liv.13670. Epub 2018 Jan 25.

PMID:
29266722
31.

Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report.

Komatsu H, Izumi N, Tsukioka T, Toda M, Hara K, Miyamoto H, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2018 Jun 20;24(3):151-153. doi: 10.5761/atcs.cr.17-00092. Epub 2017 Dec 15.

32.

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.

Hiraoka A, Michitaka K, Kumada T, Izumi N, Kadoya M, Kokudo N, Kubo S, Matsuyama Y, Nakashima O, Sakamoto M, Takayama T, Kokudo T, Kashiwabara K, Kudo M.

Liver Cancer. 2017 Nov;6(4):325-336. doi: 10.1159/000479984. Epub 2017 Sep 22.

33.

Structural basis for arginine methylation-independent recognition of PIWIL1 by TDRD2.

Zhang H, Liu K, Izumi N, Huang H, Ding D, Ni Z, Sidhu SS, Chen C, Tomari Y, Min J.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12483-12488. doi: 10.1073/pnas.1711486114. Epub 2017 Nov 8.

34.

Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy.

Toda M, Tsukioka T, Izumi N, Komatsu H, Okada S, Hara K, Miyamoto H, Ito R, Shibata T, Nishiyama N.

Thorac Cancer. 2018 Jan;9(1):112-119. doi: 10.1111/1759-7714.12547. Epub 2017 Nov 3.

35.

Simplified model of pinhole imaging for quantifying systematic errors in image shape.

Benedetti LR, Izumi N, Khan SF, Kyrala GA, Landen OL, Ma T, Nagel SR, Pak A.

Appl Opt. 2017 Nov 1;56(31):8719-8731. doi: 10.1364/AO.56.008719.

PMID:
29091687
36.

Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease.

Yada N, Tamaki N, Koizumi Y, Hirooka M, Nakashima O, Hiasa Y, Izumi N, Kudo M.

Dig Dis. 2017;35(6):515-520. doi: 10.1159/000480140. Epub 2017 Oct 17.

PMID:
29040983
37.

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.

Kudo M, Cheng AL, Park JW, Park JH, Liang PC, Hidaka H, Izumi N, Heo J, Lee YJ, Sheen IS, Chiu CF, Arioka H, Morita S, Arai Y.

Lancet Gastroenterol Hepatol. 2018 Jan;3(1):37-46. doi: 10.1016/S2468-1253(17)30290-X. Epub 2017 Oct 4.

PMID:
28988687
38.

Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.

Kaibori M, Yoshii K, Yokota I, Hasegawa K, Nagashima F, Kubo S, Kon M, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2017 Sep 15. doi: 10.1097/SLA.0000000000002526. [Epub ahead of print]

PMID:
28922205
39.

Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer.

Tsukioka T, Izumi N, Mizuguchi S, Kyukwang C, Komatsu H, Toda M, Hara K, Miyamoto H, Nishiyama N.

Int J Clin Oncol. 2018 Feb;23(1):66-72. doi: 10.1007/s10147-017-1185-z. Epub 2017 Sep 1.

PMID:
28864833
40.

Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data.

Kohsaka S, Murata T, Izumi N, Katada J, Wang F, Terayama Y.

Curr Med Res Opin. 2017 Nov;33(11):1955-1963. doi: 10.1080/03007995.2017.1374935. Epub 2017 Sep 12.

PMID:
28857611
41.

Solitary splenic metastasis from lung adenocarcinoma: A case report.

Hara K, Izumi N, Tsukioka T, Komatsu H, Toda M, Miyamoto H, Suzuki S, Kimura T, Shibata T, Nishiyama N.

Thorac Cancer. 2017 Sep;8(5):539-542. doi: 10.1111/1759-7714.12477. Epub 2017 Jul 21.

42.

Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial.

Hidaka H, Kokubu S, Sato T, Katsushima S, Izumi N, Igura T, Asahara S, Notsumata K, Osaki Y, Tsuji K, Kawanaka H, Akahoshi T, Hirota S, Matsutani S; NPB-06 study group.

Hepatol Res. 2018 Feb;48(3):E107-E116. doi: 10.1111/hepr.12934. Epub 2017 Aug 7.

PMID:
28666312
43.

Response criteria of tolvaptan for the treatment of hepatic edema.

Hiramine Y, Uojima H, Nakanishi H, Hiramatsu A, Iwamoto T, Kimura M, Kawaratani H, Terai S, Yoshiji H, Uto H, Sakaida I, Izumi N, Okita K, Koike K.

J Gastroenterol. 2018 Feb;53(2):258-268. doi: 10.1007/s00535-017-1366-6. Epub 2017 Jun 29.

PMID:
28664229
44.

Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey.

Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, Kudo M, Kubo S, Sakamoto M, Nakashima O, Kumada T, Kokudo N; Liver Cancer Study Group of Japan.

Hepatology. 2017 Aug;66(2):510-517. doi: 10.1002/hep.29225. Epub 2017 Jun 26.

PMID:
28437844
45.

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

Buti M, Gane E, Seto WK, Chan HL, Chuang WL, Stepanova T, Hui AJ, Lim YS, Mehta R, Janssen HL, Acharya SK, Flaherty JF, Massetto B, Cathcart AL, Kim K, Gaggar A, Subramanian GM, McHutchison JG, Pan CQ, Brunetto M, Izumi N, Marcellin P; GS-US-320-0108 Investigators.

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):196-206. doi: 10.1016/S2468-1253(16)30107-8. Epub 2016 Sep 22. Erratum in: Lancet Gastroenterol Hepatol. 2016 Nov;1(3):e2.

PMID:
28404092
46.

Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.

Komiyama Y, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Yasui Y, Tamaki N, Takada H, Higuchi M, Gotou T, Kubota Y, Takaura K, Hayashi T, Oh W, Okada M, Enomoto N, Izumi N.

PLoS One. 2017 Mar 31;12(3):e0174649. doi: 10.1371/journal.pone.0174649. eCollection 2017.

47.

Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.

Tamaki N, Kuno A, Matsuda A, Tsujikawa H, Yamazaki K, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Korenaga M, Mizokami M, Kurosaki M, Sakamoto M, Narimatsu H, Izumi N.

Sci Rep. 2017 Mar 21;7(1):244. doi: 10.1038/s41598-017-00357-8.

48.

Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP.

Kashihara Y, Ieiri I, Yoshikado T, Maeda K, Fukae M, Kimura M, Hirota T, Matsuki S, Irie S, Izumi N, Kusuhara H, Sugiyama Y.

J Pharm Sci. 2017 Sep;106(9):2688-2694. doi: 10.1016/j.xphs.2017.03.010. Epub 2017 Mar 18.

PMID:
28322941
49.

Mutual interaction between endothelial cells and mural cells enhances BMP9 signaling in endothelial cells.

Tachida Y, Izumi N, Sakurai T, Kobayashi H.

Biol Open. 2017 Mar 15;6(3):370-380. doi: 10.1242/bio.020503.

50.

Publisher's Note: Development of improved radiation drive environment for high foot implosions at the National Ignition Facility [Phys. Rev. Lett. 117, 225002 (2016)].

Hinkel DE, Berzak Hopkins LF, Ma T, Ralph JE, Albert F, Benedetti LR, Celliers PM, Do Ppner T, Goyon CS, Izumi N, Jarrott LC, Khan SF, Kline JL, Kritcher AL, Kyrala GA, Nagel SR, Pak AE, Patel P, Rosen MD, Rygg JR, Schneider MB, Turnbull DP, Yeamans CB, Callahan DA, Hurricane OA.

Phys Rev Lett. 2017 Feb 24;118(8):089902. doi: 10.1103/PhysRevLett.118.089902. Epub 2017 Feb 22.

PMID:
28282185

Supplemental Content

Support Center